These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 33557658)

  • 1. Suberoylanilide hydroxamic acid enhances the radiosensitivity of lung cancer cells through acetylated wild-type and mutant p53-dependent modulation of mitochondrial apoptosis.
    Wu K; Chen X; Chen X; Zhang S; Xu Y; Xia B; Ma S
    J Int Med Res; 2021 Feb; 49(2):300060520981545. PubMed ID: 33557658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone deacetylase inhibitors sensitize human non-small cell lung cancer cells to ionizing radiation through acetyl p53-mediated c-myc down-regulation.
    Seo SK; Jin HO; Woo SH; Kim YS; An S; Lee JH; Hong SI; Lee KH; Choe TB; Park IC
    J Thorac Oncol; 2011 Aug; 6(8):1313-9. PubMed ID: 21642861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suberoylanilide hydroxamic acid increases anti-cancer effect of tumor necrosis factor-α through up-regulation of TNF receptor 1 in lung cancer cells.
    You BR; Han BR; Park WH
    Oncotarget; 2017 Mar; 8(11):17726-17737. PubMed ID: 28099148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel suberoylanilide hydroxamic acid histone deacetylase inhibitor derivative, N25, exhibiting improved antitumor activity in both human U251 and H460 cells.
    Zhang S; Huang WB; Wu L; Wang LY; Ye LB; Feng BH
    Asian Pac J Cancer Prev; 2014; 15(10):4331-8. PubMed ID: 24935393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SAHA shows preferential cytotoxicity in mutant p53 cancer cells by destabilizing mutant p53 through inhibition of the HDAC6-Hsp90 chaperone axis.
    Li D; Marchenko ND; Moll UM
    Cell Death Differ; 2011 Dec; 18(12):1904-13. PubMed ID: 21637290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, enhances radiosensitivity and suppresses lung metastasis in breast cancer in vitro and in vivo.
    Chiu HW; Yeh YL; Wang YC; Huang WJ; Chen YA; Chiou YS; Ho SY; Lin P; Wang YJ
    PLoS One; 2013; 8(10):e76340. PubMed ID: 24130769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of rapamycin and SAHA enhanced radiosensitization by inducing autophagy and acetylation in NSCLC.
    Wang Y; Liu F; Fang C; Xu L; Chen L; Xu Z; Chen J; Peng W; Fu B; Li Y
    Aging (Albany NY); 2021 Jul; 13(14):18223-18237. PubMed ID: 34321364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suberoylanilide hydroxamic acid combined with gemcitabine enhances apoptosis in non-small cell lung cancer.
    Rundall BK; Denlinger CE; Jones DR
    Surgery; 2005 Aug; 138(2):360-7. PubMed ID: 16153448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor effects of histone deacetylase inhibitor suberoylanilide hydroxamic acid in epidermal growth factor receptor-mutant non-small-cell lung cancer lines in vitro and in vivo.
    Wei Y; Zhou F; Lin Z; Shi L; Huang A; Liu T; Yu D; Wu G
    Anticancer Drugs; 2018 Mar; 29(3):262-270. PubMed ID: 29356692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of tumor initiation and expression of KCNMA1, MORF4L2 and ASPM genes in the adenocarcinoma of lung xenograft after vorinostat treatment.
    Kuo WY; Wu CY; Hwu L; Lee JS; Tsai CH; Lin KP; Wang HE; Chou TY; Tsai CM; Gelovani J; Liu RS
    Oncotarget; 2015 Apr; 6(11):8663-75. PubMed ID: 25796627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined Effects of Suberoylanilide Hydroxamic Acid and Cisplatin on Radiation Sensitivity and Cancer Cell Invasion in Non-Small Cell Lung Cancer.
    Feng J; Zhang S; Wu K; Wang B; Wong JY; Jiang H; Xu R; Ying L; Huang H; Zheng X; Chen X; Ma S
    Mol Cancer Ther; 2016 May; 15(5):842-53. PubMed ID: 26839308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suberoylanilide hydroxamic acid (SAHA) enhances olaparib activity by targeting homologous recombination DNA repair in ovarian cancer.
    Konstantinopoulos PA; Wilson AJ; Saskowski J; Wass E; Khabele D
    Gynecol Oncol; 2014 Jun; 133(3):599-606. PubMed ID: 24631446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiosensitization by SAHA in experimental colorectal carcinoma models-in vivo effects and relevance of histone acetylation status.
    Folkvord S; Ree AH; Furre T; Halvorsen T; Flatmark K
    Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):546-52. PubMed ID: 19427556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of caspases, Bid, and p53 in the apoptotic response triggered by histone deacetylase inhibitors trichostatin-A (TSA) and suberoylanilide hydroxamic acid (SAHA).
    Henderson C; Mizzau M; Paroni G; Maestro R; Schneider C; Brancolini C
    J Biol Chem; 2003 Apr; 278(14):12579-89. PubMed ID: 12556448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The anti-tumor effects and molecular mechanisms of suberoylanilide hydroxamic acid (SAHA) on the aggressive phenotypes of ovarian carcinoma cells.
    Chen S; Zhao Y; Gou WF; Zhao S; Takano Y; Zheng HC
    PLoS One; 2013; 8(11):e79781. PubMed ID: 24236158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel histone deacetylase inhibitor CG200745 induces clonogenic cell death by modulating acetylation of p53 in cancer cells.
    Oh ET; Park MT; Choi BH; Ro S; Choi EK; Jeong SY; Park HJ
    Invest New Drugs; 2012 Apr; 30(2):435-42. PubMed ID: 20978925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suberoylanilide hydroxamic acid induces thioredoxin1-mediated apoptosis in lung cancer cells via up-regulation of miR-129-5p.
    You BR; Park WH
    Mol Carcinog; 2017 Dec; 56(12):2566-2577. PubMed ID: 28667779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo efficacy of the histone deacetylase inhibitor suberoylanilide hydroxamic acid in combination with radiotherapy in a malignant rhabdoid tumor mouse model.
    Thiemann M; Oertel S; Ehemann V; Weichert W; Stenzinger A; Bischof M; Weber KJ; Perez RL; Haberkorn U; Kulozik AE; Debus J; Huber PE; Battmann C
    Radiat Oncol; 2012 Mar; 7():52. PubMed ID: 22458853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone deacetylase inhibitors induce in human hepatoma HepG2 cells acetylation of p53 and histones in correlation with apoptotic effects.
    Carlisi D; Vassallo B; Lauricella M; Emanuele S; D'Anneo A; Di Leonardo E; Di Fazio P; Vento R; Tesoriere G
    Int J Oncol; 2008 Jan; 32(1):177-84. PubMed ID: 18097557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of SAHA on radiosensitivity in pancreatic cancer cells by inducing apoptosis and targeting RAD51.
    Wu Z; Jing S; Li Y; Gao Y; Yu S; Li Z; Zhao Y; Piao J; Ma S; Chen X
    Biomed Pharmacother; 2017 May; 89():705-710. PubMed ID: 28267674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.